Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Characterization of Immunophenotypic Aberrancies in Adult and Childhood Acute Lymphoblastic Leukemia: Lessons from Regional Variation.

Rezaei MS, Esfandiari N, Refoua S, Shamaei M.

Iran J Pathol. 2020 Winter;15(1):1-7. doi: 10.30699/IJP.2019.93974.1926.

2.

The Relation between Polymorphisms in Exon 5 and Exon 6 of GSTP1 Gene and the Risk of Lung Cancer in Iranian People

Shahsavari G, Amiri A, Shamaei M, Adibhesami G, Emami Razavi A, Birjandi M, Pourabdollah M.

Asian Pac J Cancer Prev. 2019 May 25;20(5):1503-1509.

3.

Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) Polymorphisms and Lung Cancer Risk among a Select Group of Iranian People

Adibhesami G, Shahsavari GR, Amiri A, Emami Razavi AN, Shamaei M, Birjandi M.

Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2921-2927.

4.

Implementing Tuberculosis Close-contact Investigation in a Tertiary Hospital in Iran.

Shamaei M, Esmaeili S, Marjani M, Tabarsi P.

Int J Prev Med. 2018 May 16;9:48. doi: 10.4103/ijpvm.IJPVM_5_16. eCollection 2018.

5.

Differential role of gpaB and sidA gene expressions in relation to virulence in Aspergillus species from patients with invasive aspergillosis.

Ghods N, Falahati M, Roudbary M, Farahyar S, Shamaei M, Pourabdollah M, Seif F.

Braz J Microbiol. 2018 Jul - Sep;49(3):668-674. doi: 10.1016/j.bjm.2017.10.003. Epub 2018 Feb 3.

6.

Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity.

Shamaei M, Mortaz E, Pourabdollah M, Garssen J, Tabarsi P, Velayati A, Adcock IM.

Hum Immunol. 2018 Jan;79(1):63-69. doi: 10.1016/j.humimm.2017.10.009. Epub 2017 Oct 31.

7.

Risk factors for readmission to hospital in patients with tuberculosis in Tehran, Iran: three-year surveillance.

Shamaei M, Samiei-Nejad M, Nadernejad M, Baghaei P.

Int J STD AIDS. 2017 Oct;28(12):1169-1174. doi: 10.1177/0956462417691442. Epub 2017 Feb 6.

PMID:
28166697
8.

Immunohistochemical findings of the granulomatous reaction associated with tuberculosis.

Karimi S, Shamaei M, Pourabdollah M, Sadr M, Karbasi M, Kiani A, Bahadori M.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S234-S235. doi: 10.1016/j.ijmyco.2016.11.001. Epub 2016 Nov 11.

9.

Insertion/Deletion Polymorphisms and Serum Angiotensin-converting Enzyme Levels in Iranian Patients with Sarcoidosis.

Javadi A, Shamaei M, Zarei M, Rezaeian L, Kiani A, Abedini A.

Iran J Public Health. 2016 Nov;45(11):1473-1480.

10.

The Intricate Expression of CC Chemokines in Glial Tumors: Evidence for Involvement of CCL2 and CCL5 but Not CCL11.

Moogooei M, Shamaei M, Khorramdelazad H, Fattahpour S, Seyedmehdi SM, Moogooei M, Hassanshahi G, Kalantari Khandani B.

Acta Med Iran. 2015 Dec;53(12):770-7.

11.

Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens.

Shamaei M, Mirsaeidi M, Baghaei P, Mosaei H, Marjani M, Tabarsi P.

Am J Ther. 2017 Mar/Apr;24(2):e144-e149. doi: 10.1097/MJT.0000000000000218.

12.

Evaluation of in-house polymerase chain reaction assay sensitivity, can it be utilized in limited-resources settings?

Dorudinia A, Shamaei M, Karimi S, Javadi A, Mohammadi Ziazi L, Pourabdollah M.

Med J Islam Repub Iran. 2014 Nov 8;28:126. eCollection 2014.

13.

Transbronchial lung biopsy: the pathologist's point of view.

Pourabdollah M, Shamaei M, Karimi S, Karimi M, Kiani A, Jabbari HR.

Clin Respir J. 2016 Mar;10(2):211-6. doi: 10.1111/crj.12207. Epub 2014 Nov 9.

PMID:
25185518
14.

Histopathological findings in immunohistological staining of the granulomatous tissue reaction associated with tuberculosis.

Karimi S, Shamaei M, Pourabdollah M, Sadr M, Karbasi M, Kiani A, Bahadori M.

Tuberc Res Treat. 2014;2014:858396. doi: 10.1155/2014/858396. Epub 2014 Jan 5.

15.

Qualification study of two genomic DNA extraction methods in different clinical samples.

Javadi A, Shamaei M, Mohammadi Ziazi L, Pourabdollah M, Dorudinia A, Seyedmehdi SM, Karimi S.

Tanaffos. 2014;13(4):41-7.

16.

Nocardiosis: risk factors, clinical characteristics and outcome.

Alavi Darazam I, Shamaei M, Mobarhan M, Ghasemi S, Tabarsi P, Motavasseli M, Mansouri D.

Iran Red Crescent Med J. 2013 May;15(5):436-9. doi: 10.5812/ircmj.2384. Epub 2013 May 5.

17.

Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis.

Marjani M, Baghaei P, Tabarsi P, Shamaei M, Mansouri D, Masjedi MR, Velayati A.

East Mediterr Health J. 2012 Sep;18(9):957-61.

18.

Pulmonary disease caused by Mycobacterium simiae in Iran's national referral center for tuberculosis.

Baghaei P, Tabarsi P, Farnia P, Marjani M, Sheikholeslami FM, Chitsaz M, Gorji Bayani P, Shamaei M, Mansouri D, Masjedi MR, Velayati AA.

J Infect Dev Ctries. 2012 Jan 12;6(1):23-8.

19.

Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy.

Tabarsi P, Moradi A, Baghaei P, Marjani M, Shamaei M, Mansouri N, Chitsaz E, Farnia P, Mansouri D, Masjedi M, Velayati A.

Int J Tuberc Lung Dis. 2011 Apr;15(4):547-50. doi: 10.5588/ijtld.10.0140.

PMID:
21396217
20.

Tuberculosis-associated secondary pneumothorax: a retrospective study of 53 patients.

Shamaei M, Tabarsi P, Pojhan S, Ghorbani L, Baghaei P, Marjani M, Masjedi MR.

Respir Care. 2011 Mar;56(3):298-302. doi: 10.4187/respcare.00695. Epub 2011 Jan 21.

21.

Detection of Antibodies Against 6, 16 and 38 kDa Antigens of Mycobacterium tuberculosis as a Rapid Test for Diagnosis of Tuberculosis.

Baghaei P, Tabarsi P, Sabour H, Dehghani S, Marjani M, Shamaei M, Jabbari A, Amiri MV, Velayati AA.

Tanaffos. 2011;10(4):17-22.

22.

Association between chronic periodontitis and serum lipid levels.

Taleghani F, Shamaei M, Shamaei M.

Acta Med Iran. 2010 Jan-Feb;48(1):47-50.

23.

Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.

Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.

Am J Ther. 2011 Sep;18(5):343-9. doi: 10.1097/MJT.0b013e3181dd60ec.

PMID:
20535008
24.

Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.

Tabarsi P, Chitsaz E, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Amiri M, Mansouri D, Masjedi MR, Velayati AA, Caminero JA.

Microb Drug Resist. 2010 Mar;16(1):81-6. doi: 10.1089/mdr.2009.0073.

PMID:
20192820
25.

Human infections due to Mycobacterium lentiflavum: first report in Iran.

Shamaei M, Marjani M, Farnia P, Tabarsi P, Mansouri D.

Iran J Microbiol. 2010 Mar;2(1):27-9.

26.

Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.

Baghaei P, Tabarsi P, Dorriz D, Marjani M, Shamaei M, Pooramiri MV, Mansouri D, Farnia P, Masjedi M, Velayati A.

Am J Ther. 2011 Mar-Apr;18(2):e29-34. doi: 10.1097/MJT.0b013e3181c0806d.

PMID:
20019591
27.

Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis.

Shamaei M, Marjani M, Baghaei P, Chitsaz E, Rezaei Tabar E, Abrishami Z, Tabarsi P, Mansouri D, Masjedi MR.

Int J STD AIDS. 2009 May;20(5):320-3. doi: 10.1258/ijsa.2008.008299.

PMID:
19386968
28.

First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.

Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.

Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.

Supplemental Content

Loading ...
Support Center